Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Works matching IS 11732563 AND DT 2019 AND VI 39 AND IP 9
Results: 11
1
2
Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
3
Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 899, doi. 10.1007/s40261-019-00814-4
- By:
- Publication type:
- Article
4
Drug–Drug Interactions in Children and Adolescents Receiving Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C Virus Infection.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 857, doi. 10.1007/s40261-019-00805-5
- By:
- Publication type:
- Article
5
Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 847, doi. 10.1007/s40261-019-00810-8
- By:
- Publication type:
- Article
6
Determinants of Antithrombotic Treatment for Atrial Fibrillation in Octogenarians: Results of the OCTOFA Study.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 891, doi. 10.1007/s40261-019-00809-1
- By:
- Publication type:
- Article
7
Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel Na<sub>V</sub>1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 873, doi. 10.1007/s40261-019-00832-2
- By:
- Publication type:
- Article
8
Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 865, doi. 10.1007/s40261-019-00806-4
- By:
- Publication type:
- Article
9
Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 825, doi. 10.1007/s40261-019-00811-7
- By:
- Publication type:
- Article
10
Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 909, doi. 10.1007/s40261-019-00804-6
- By:
- Publication type:
- Article
11
Bayesian Network Meta-Analysis for Assessing Adverse Effects of Anti-hepatitis B Drugs.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 9, p. 835, doi. 10.1007/s40261-019-00802-8
- By:
- Publication type:
- Article